20+ Years
20 Years
Of Experience
The Largest Network Of Laboratories provider of Testing Center.
Mauris ut enim sit amet lacus ornare ullamcorper. Praesent placerat neque eu purus rhoncus, vel tincidunt odio ultrices. Sed feugiat feugiat felis. Curabitur posuere tristique mauris non blandit. Sed consectetur venenatis enim, vitae vestibulum ipsum tincidunt in. Fusce et nulla vulputate, pellentesque leo non, bibendum orci.
Blood Bank & Chemistry Center
Chemical Research & Testing Center
Latest Case Studies
- Biochemics
- Hormones
- Allergies
- Microbiology
Our Success Journey Choose We can Provide.
Mauris ut enim sit amet lacus ornare ullamcorper. Praesent placerat neque eu purus rhoncus, vel tincidunt odio ultrices. Sed feugiat feugiat felis. Curabitur posuere tristique mauris non blandit. Sed consectetur venenatis enim, vitae vestibulum ipsum tincidunt in. Fusce et nulla vulputate, pellentesque leo non, bibendum orci.
Improving Your Health
Trust Shared Purpose
Better Health Outcomes
Empowered to Change
Innovations In Vaccines
Strict Quality Practices
Latest News & Blogs
Praesent efficitur nulla. Pellentesque commodo lorem.
Praesent efficitur nulla. Pellentesque commodo lorem.
Mauris vitae dolor sagittis sem placerat lacinia.
Exploring Anatomy Member
University of Pennsylvania
About Me:
Dr. Charles Russell is the Chief Scientific Officer for Oncology Research and Development. Dr. Russell leads all oncology research from the beginning stages of discovery to proof of concept clinical studies. Dr. Russell is an internationally recognized leader in molecularly targeted cancer therapeutics, the epigenetics of cancer drug resistance, and personalized cancer medicine. Dr. Russell held numerous notable positions in both academic research and drug discovery before joining the Brifolipharm team. . Dr. Russell received his Ph.D. in Genetics from Yale University and his B.A. in Neuroscience from the University of Pennsylvania.
Emergency CasesSwarthmore College
About Me:
I joined Brifolipharm pharmaceuticals in 2015 and currently serve as Senior Director and Patient Advocacy Lead in Brifolipharm’s Rare Disease Research Unit. I am a healthcare professional with experience in patient advocacy, public affairs, program development, medical communications/education, basic and clinical research in pharmaceutical and academic clinical settings. I lead the strategic planning and implementation of collaborations with third party patient advocacy groups in support of the Rare Disease Research Unit’s programmatic areas of priority. In my role, I am external facing, engaging with rare disease patient advocacy groups to integrate their expertise and expertise into our discovery and development plans to drive our early drug development programs. I am also internal facing, helping to drive alignment and communication among cross-functional colleagues advancing our science and programs along the rare disease drug development continuum with rare disease patient communities. Prior to joining Brifolipharm, I have built or joined patient advocacy teams in several biopharmaceutical companies, operationalizing these roles in various functions. I am professionally trained as a Genetic Counselor, having spent 10 years in academic medicine as a Genetic Counselor at both New York Presbyterian Hospital-Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center before entering industry. I received my BA from Swarthmore College and Masters of Science in Human Genetics from Sarah Lawrence College.
Emergency CasesSwarthmore College
About Me:
I joined Brifolipharm pharmaceuticals in 2015 and currently serve as Senior Director and Patient Advocacy Lead in Brifolipharm’s Rare Disease Research Unit. I am a healthcare professional with experience in patient advocacy, public affairs, program development, medical communications/education, basic and clinical research in pharmaceutical and academic clinical settings. I lead the strategic planning and implementation of collaborations with third party patient advocacy groups in support of the Rare Disease Research Unit’s programmatic areas of priority. In my role, I am external facing, engaging with rare disease patient advocacy groups to integrate their expertise and expertise into our discovery and development plans to drive our early drug development programs. I am also internal facing, helping to drive alignment and communication among cross-functional colleagues advancing our science and programs along the rare disease drug development continuum with rare disease patient communities. Prior to joining Brifolipharm, I have built or joined patient advocacy teams in several biopharmaceutical companies, operationalizing these roles in various functions. I am professionally trained as a Genetic Counselor, having spent 10 years in academic medicine as a Genetic Counselor at both New York Presbyterian Hospital-Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center before entering industry. I received my BA from Swarthmore College and Masters of Science in Human Genetics from Sarah Lawrence College.
Emergency CasesNetherland Medical College
About Me:
Nunc fringilla est nec lobortis dictum. Fusce a dolor risus. Ut suscipit arcu sed turpis rhoncus dapibus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Aenean fringilla nunc diam, ac elementu justo pellentesque in. Sed elementum elem quam at elementum. Vestibulum et mollis metus. Fusce porttitor laoreet urna, eget luctus puru rhoncus non. Sed faucibus purus at tincidunt tristique.
Emergency Cases